Author:
Peck Megan E.,Lucas Todd,Ong Katherine S.,Grund Jonathan M.,Davis Stephanie,Yansaneh Aisha,Kiggundu Valerian L.,Thomas Anne G.,Curran Kelly,Laube Catharine,Sundaram Maaya,Ameyan Wole,Zembe Lycias,Toledo Carlos
Abstract
AbstractPurpose of ReviewSince 2007, voluntary medical male circumcision (VMMC) programs have been associated with substantially reduced HIV incidence across 15 prioritized countries in Eastern and Southern Africa. Drawing on the programmatic experience of global VMMC leaders, this report reviews progress made in the first 15 years of the program, describes programmatic and research gaps, and presents considerations to maximize the impact of VMMC.Recent FindingsOverall, key programmatic and research gaps include a lack of robust male circumcision coverage estimates due to limitations to the data and a lack of standardized approaches across programs; challenges enhancing VMMC uptake include difficulties reaching populations at higher risk for HIV infection and men 30 years and older; limitations to program and procedural quality and safety including variations in approaches used by programs; and lastly, sustainability with limited evidence-based practices. Considerations to address these gaps include the need for global guidance on estimating coverage, conducting additional research on specific sub-populations to improve VMMC uptake, implementation of responsive and comprehensive approaches to adverse event surveillance, and diversifying financing streams to progress towards sustainability.SummaryThis report’s findings may help establish a global VMMC research and programmatic agenda to inform policy, research, and capacity-building activities at the national and global levels.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference64 articles.
1. World Health Organization, Joint United Nations Programme on HIV/AIDS. WHO/UNAIDS Technical Consultation on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming. 2007. http://www.unaids.org/sites/default/files/media_asset/mc_recommendations_en_1.pdf. Accessed 15 February 2022.
2. Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, Bailey R, Cherutich P, et al. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. JAIDS. 2012;60:S88.
3. Davis SM, Hines JZ, Habel M, Grund JM, Ridzon R, Baack B, et al. Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data. BMJ Open. 2018;8: e021835. https://doi.org/10.1136/bmjopen-2018-021835.
4. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56. https://doi.org/10.1016/S0140-6736(07)60312-2.
5. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献